Live tape
Top 8, mentions 7d13,852TSLA3,216 mentions▲ +0.05SPCX2,646 mentions▲ +0.08GOOGL1,857 mentions▲ +0.03META1,819 mentions▲ +0.05QQQ1,141 mentions▲ +0.05NVDA1,087 mentions▲ +0.07CRWV1,048 mentions▲ +0.04NFLX1,038 mentions▲ +0.03

Equity · Healthcare

MRK

NYSE

Merck & Co. (MRK)

$149.88 +1.05% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 21, 2026

Reddit mentioned MRK 16 times in the 30 days to 22 October 2026, across 5 of the communities we track. All of them were scored for sentiment: 56% read bullish, 19% bearish and 25% neither. Reddit data updated 22 October 2026.

Price · Chart
63 sessions
$160 $120 24 Jul 21 Oct

The line runs $131.11 on 24 July through $149.88 on 21 October, on a scale from $120 to $160. Days the market did not trade hold the previous close, flat.

Market cap $369.8B
P/E (TTM) 119.9
52-week range $82.49 – $156.44
Avg volume 381.4K
Mentions · 30d 16
Net sentiment +0.19

as of Oct 21, 2026

Merck & Co. (MRK) · crowd attention × price

Share ↗
16 mentions

Day21 Oct 2026

MENTIONS00–4 / day
PRICE$149.88$135–$150
MRK over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day01234usd$135$140$145$15023 Sep30 Sep8 Oct15 Oct22 Oct
MRK over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.23 Sep8 Oct22 Oct
The Distributed Sentinel 22 Oct 2026

Reddit's attention on MRK arrived in one burst — 3 of this window's 16 mentions landed on 22 October alone

This chart in words

The chart plots daily Reddit mentions of MRK over the 30 days to 22 October 2026: 16 in total, busiest on 22 October with 3, and 3 on the last day counted. The line is the daily close over the same window: $148.10 on 23 September, $149.88 on 21 October. Of those days, 21 were trading sessions and the other 9 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Merck & Co. (MRK) on Reddit · 30d

n = 16 scored · Method

In the 30 days to 23 Oct 2026, Merck & Co. drew 16 Reddit mentions in the finance subreddits we track, 16 of them scored for sentiment.

MRK

56% bullish

Overall market sentiment

54% bullish

MRK reads 2 points more bullish than overall market sentiment. Same measure; same 30-day window.

Where MRK is discussed

(30d)
r/wallstreetbets 60% 9 +0.11
r/options 13% 2 +0.06
r/stocks 13% 2 +0.80
r/etfs 7% 1 +0.18
r/investing 7% 1 +0.02

Moves with MRK

co-mention r · 31 obs

Tickers whose daily Reddit volume rose and fell with MRK's. Co-discussion, not price.

How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations) · Method

What Reddit is saying about Merck & Co. (MRK)

The threads carrying the mentions · 30 days

Live discussion on Reddit, shown as posted. Titles link to the original threads.

Merck & Co. (MRK) insider trades

SEC Form 4 · last 90 days · newest reported trade 13 Aug 2026

In the 90 days to 23 Oct 2026, Merck & Co. insiders reported 9 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 30 Sep 2025, show no open-market purchase.

Open-market buys 0
Open-market sells 9
Net sold $29.98M
Non-trade filings 3
Date Insider Type Shares Value
13 Aug 2026 Guindo Chirfi EVP, Access, Policy & Comms Sell 10,000 $1.35M
12 Aug 2026 DeLuca Richard R. EVP&Pres, Merck Animal Heallth Sell 11,699 $1.54M
12 Aug 2026 Zachary Jennifer EVP, General Counsel Sell 80,315 $10.72M
11 Aug 2026 DeLuca Richard R. EVP&Pres, Merck Animal Heallth Sell 12,837 $1.69M
10 Aug 2026 DeLuca Richard R. EVP&Pres, Merck Animal Heallth Sell 20,784 $2.71M
06 Aug 2026 Guindo Chirfi EVP, Access, Policy & Comms Sell 15,000 $1.97M
06 Aug 2026 DeLuca Richard R. EVP&Pres, Merck Animal Heallth Sell 6,050 $789K
05 Aug 2026 Maraldo David R. EVP & Pres. MMD Sell 18,706 $2.41M
05 Aug 2026 Williams David Michael EVP,Chief Info&Digital Officer Sell 52,847 $6.81M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
12 Aug 2026 Zachary Jennifer EVP, General Counsel Option exercise 54,927 $6.03M
05 Aug 2026 Maraldo David R. EVP & Pres. MMD Option exercise 18,706 $1.54M
05 Aug 2026 Williams David Michael EVP,Chief Info&Digital Officer Option exercise 52,847 $3.94M

Merck & Co. (MRK) reported financials

SEC EDGAR XBRL SEC EDGAR

Merck & Co. reported revenue of $65.0B for the fiscal year ended 31 Dec 2025. Net income over the same period was $18.3B.

Figure Reported Period
Revenue $65.0B 31 Dec 2025 fiscal year
Net income $18.3B 31 Dec 2025 fiscal year
Diluted EPS $7.28 31 Dec 2025 fiscal year
Total assets $129.8B 30 Jun 2026 at period end
Total equity $41.9B 30 Jun 2026 at period end

Merck & Co. (MRK) earnings

SEC EDGAR

Merck & Co. last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.54; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.54 $16.61B
31 Mar 2026 Q1 2026 −$1.72 $16.29B
31 Dec 2025 FY 2025 $7.28 $65.01B
30 Sep 2025 Q3 2025 $2.32 $17.28B
30 Jun 2025 Q2 2025 $1.76 $15.81B
31 Mar 2025 Q1 2025 $2.01 $15.53B
31 Dec 2024 FY 2024 $6.74 $64.17B
30 Sep 2024 Q3 2024 $1.24 $16.66B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Merck & Co. (MRK) institutional holders (13F)

SEC Form 13F SEC EDGAR

11 of the 45 institutional funds we track reported a Merck & Co. position for the quarter ended 30 Jun 2026 — a combined $6.9B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Fisher Asset Management Added +45.7% shares 38,516,263 $4.9B
AQR Capital Management Held (±25%) −5.7% shares 8,134,262 $1.0B
D. E. Shaw & Co. Held (±25%) −19.4% shares 2,738,023 $351.8M
Citadel Advisors Trimmed −49.4% shares 1,933,667 $248.5M
Man Group Held (±25%) +24.9% shares 990,469 $127.3M
Millennium Management Trimmed −71.5% shares 561,302 $72.1M
Point72 Asset Management Trimmed −58.7% shares 380,081 $48.8M
GAMCO Investors Held (±25%) −3.2% shares 62,672 $8.1M
Balyasny Asset Management Trimmed −96.9% shares 56,028 $7.2M
Two Sigma Investments Held (±25%) −24.4% shares 48,625 $6.2M

Showing the 10 largest of 11 reported positions. The figures above count all of them.

Merck & Co. (MRK) fails-to-deliver

SEC CNS data SEC

On 30 Sep 2026, 5,675 shares of Merck & Co. failed to deliver (about $847K).

Settlement date Shares failed Notional % of shares out
30 Sep 2026 5,675 $847K <0.001%
25 Sep 2026 71 $11K <0.001%
15 Sep 2026 6,473 $938K <0.001%
14 Sep 2026 5,052 $727K <0.001%
08 Sep 2026 7,268 $1.1M <0.001%

Congressional trades in Merck & Co. (MRK)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Merck & Co. is a sale by Maria Elvira Salazar (house, FL), dated 24 Sep 2026.

Date Member Type Amount
24 Sep 2026 filed 07 Oct 2026 Maria Elvira Salazar house · Republican–FL Sale $1K–$15K
19 Aug 2026 filed 09 Sep 2026 Maria Elvira Salazar house · Republican–FL Purchase $15K–$50K
19 Dec 2025 filed 12 Jan 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
18 Dec 2025 filed 15 Jan 2026 Julie Johnson house · Democrat–TX Sale $1K–$15K
18 Nov 2025 filed 15 Dec 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
13 Nov 2025 filed 11 Dec 2025 Julie Johnson house · Democrat–TX Sale $1K–$15K
23 Sep 2025 filed 10 Oct 2025 Val T. Hoyle house · Democrat–OR Sale $1K–$15K
14 Aug 2025 filed 11 Sep 2025 Julie Johnson house · Democrat–TX Sale $1K–$15K

Merck & Co. (MRK): frequently asked questions

From live data

Have Merck & Co. insiders bought or sold shares recently?

In the 90 days to 23 Oct 2026, Merck & Co. insiders reported 9 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 30 Sep 2025, show no open-market purchase. A further 3 filings were grants, awards, gifts or exercises rather than open-market trades.

How many institutions hold Merck & Co.?

11 of the 45 institutional funds we track reported a Merck & Co. position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Merck & Co. had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Merck & Co. is dated 30 Sep 2026, when 5,675 shares failed to deliver.

When did Merck & Co. last report earnings?

Merck & Co. last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.54; no next date is announced in SEC filings yet.

What exchange is Merck & Co. listed on?

Merck & Co. trades on NYSE under the ticker MRK.

Who is the CEO of Merck & Co.?

Rob Davis leads Merck & Co. (MRK) as chief executive.

What is Reddit saying about Merck & Co.?

Merck & Co. was mentioned 8 times in the last 7 days across the finance subreddits we track, and 16 times over the trailing 30 days. Of 16 classified mentions, 56% read bullish, 19% bearish and 25% neutral. Crowd sentiment is a social signal, not investment advice.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SEC EDGARValuation computed from SEC EDGAR filings